SCHEMBL9315905

SCHEMBL9315905

CCOC(=O)CC(C[N+](=O)[O-])c1cc2cc(CC)ccc2o1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.42
CA2 P00918 2/20 0.42
CA3 P07451 2/20 0.42
CA6 P23280 2/20 0.42
CA7 P43166 2/20 0.42
CA9 Q16790 2/20 0.42
CA14 Q9ULX7 2/20 0.42
CA5B Q9Y2D0 2/20 0.42
CA4 P22748 1/20 0.42
LMNA P02545 4/20 0.39
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 2/20 0.39
MAOB P27338 2/20 0.37
MAOA P21397 1/20 0.37
THRB P10828 2/20 0.36
TP53 P04637 2/20 0.36
MAPT P10636 1/20 0.35
CA5A P35218 1/20 0.34
F2 P00734 1/20 0.34
F10 P00742 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9315765 0.89 TAS1R3 (0.41) CA12CA2CA3CA6CA7
SCHEMBL9316716 0.88 ALDH1A1 (0.43) CA12CA9LMNAKDM4EALDH1A1
SCHEMBL9315814 0.87 TP53 (0.48) LMNAKDM4EALDH1A1MAOBTHRB
SCHEMBL9315934 0.87 KDM4E (0.39) CA12CA2CA3CA6CA7
SCHEMBL9315029 0.86 KDM4E (0.40) LMNAKDM4EALDH1A1MAOBMAOA
SCHEMBL9315780 0.84 LMNA (0.39) LMNAKDM4EALDH1A1MAOBMAOA
SCHEMBL9315898 0.79 LMNA (0.34) CA12CA2CA3CA6CA7
SCHEMBL25777700 0.70 CA12 (0.59) CA12CA2CA3CA6CA7
SCHEMBL482069 0.70 MAPT (0.46) LMNAKDM4EALDH1A1MAPTF2
SCHEMBL9201733 0.70 ALOX5 (0.43) LMNAKDM4EALDH1A1MAOBTHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5278166-A 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1994-01-11 US disclosed
US-5214063-A 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1993-05-25 US disclosed
US-5162364-A Treatment of spastic and senescence disorders ADIR ET COMPAGNIE (FR) 1992-11-10 US disclosed